Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia (original) (raw)

References

  1. Aarsland D, Tandberg E, Larsen JP, Cummings JL (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53(6):538–542
    PubMed CAS Google Scholar
  2. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh–Sørensen P (2003) Prevalence and characteristics of dementia in Parkinson disease. An 8–year prospective study. Arch Neurol 60:387–392
    Google Scholar
  3. American Psychiatric Association (2003) Manual diagnóstico y estadístico de los trastornos mentales, Cuarta edición revisada: DSM–IV–TR. Masson SA, Barcelona
  4. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology. Laterdeveloping dementia and loss of the levodopa response. Arch Neurol 59:102–112
    Article PubMed Google Scholar
  5. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson’s disease. Acta Neuropathol (Berl) 88:493–500
    PubMed CAS Google Scholar
  6. Braak H, Braak E (2000) Pathoanatomy of Parkinson’s disease. J Neurol 247 (Suppl 2):II/3–II/10
    Google Scholar
  7. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
    Article PubMed Google Scholar
  8. Burn DJ (2004) Cortical Lewy body disease. J Neurol Neurosurg Psychiatry 75:175–178
    Article PubMed CAS Google Scholar
  9. Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800. DOI: 10.1093/brain/awh088
    Article PubMed Google Scholar
  10. Calopa M, Tolosa E, Ferrer I, Rey MJ, Cardozo A, Martí MJ, Ribalta T (2002) Cortical Lewy bodies in Parkinson’s disease with dementia. In: Tolosa E, Schulz JB, McKeith IG, Ferrer I (eds) Neurodegenerative disorders associated with α–Synuclein pathology. Medicina stm Editores, SL, Barcelona, pp 127–134
  11. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18(7):784–790
    Article PubMed Google Scholar
  12. Daniel SE, Lees AJ (1993) Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165–172
    PubMed CAS Google Scholar
  13. de la Monte SM, Wells SE, Hedley– Whyte ET, Growdon JH (1989) Neuropathological distinction between Parkinson’s dementia and Parkinson’s plus Alzheimer's disease. Ann Neurol 26:309–320
    Article PubMed CAS Google Scholar
  14. De Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF (1995) 'Lewy body disease': clinico–pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22
    PubMed CAS Google Scholar
  15. Diederich NJ, Goetz CG, Stebbins GT (2005) Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20(2):130–140. DOI: 10.1002/mds 0.20308
    PubMed Google Scholar
  16. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2–8
    Google Scholar
  17. Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R and the Parkinson Study Group (2003) Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 60:1756–1761
    PubMed CAS Google Scholar
  18. Fahn S, Elton RL and members of the UPDRS development committee (1987) Unified Idiopathic Parkinson's disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease (Vol. 2). Florham Park, New Jersey, Mac Millan Healthcare Information, USA, pp 153–164
  19. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283–2301
    PubMed Google Scholar
  20. Folstein MF, Folstein SE, McHugh PR (1975) "Mini–mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198
    Article PubMed CAS Google Scholar
  21. Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB (2001) Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 57:2078–2082
    PubMed CAS Google Scholar
  22. Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC (1998) Cognitive and motor functioning in Parkinson disease. Arch Neurol 55:674–680
    Article PubMed CAS Google Scholar
  23. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel–based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36. DOI: 10.1006/nimg 0.2001.0786
    PubMed CAS Google Scholar
  24. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
    PubMed CAS Google Scholar
  25. Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391–403
    PubMed CAS Google Scholar
  26. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ (2001) Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 108:571–580
    Article PubMed CAS Google Scholar
  27. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha–synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54(10):1916–1921
    PubMed CAS Google Scholar
  28. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W and the Parkinson Study Group (1990) Variable expression of Parkinson's disease: A base–line analysis of the DATATOP cohort. Neurology 40:1529–1534
    PubMed CAS Google Scholar
  29. Kaasinen V, Aalto S, Någren K, Hietala J, Sonninen P, Rinne JO (2003) Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study. J Neural Transm 110:591–601. DOI: 10.1007/s00702–003–0816–x
    Article PubMed CAS Google Scholar
  30. Kawabata K, Tachibana H, Sugita M (1991) Cerebral blood flow and dementia in Parkinson's disease. J Geriatr Psychiatry Neurol 4(4):194–203
    PubMed CAS Google Scholar
  31. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, Kinomura S, Fukuda H, Chida K, Okita N, Takase S, Itoyama Y (2001) Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 193:29–36
    Article PubMed CAS Google Scholar
  32. Levy G, Jacobs DM, Tang M, Côté LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002a) Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 17(6):1221–1226. DOI: 10.1002/mds 0.10280
    Google Scholar
  33. Levy G, Schupf N, Tang M, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K (2002b) Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 51:722–729. DOI: 10.1002/ana 0.10219
    Google Scholar
  34. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004) Neuropsychological assessment. 4th ed. Oxford University Press Inc., New York
  35. Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 53(2):81–102
    PubMed CAS Google Scholar
  36. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, Imabayashi E, Katoh A (2002) Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J Nucl Med 43:304–311
    PubMed Google Scholar
  37. Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000) Alphasynuclein– immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol (Berl)100:285–290
    Article PubMed CAS Google Scholar
  38. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population–based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 49(5):492–497
    PubMed CAS Google Scholar
  39. Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO (2003) Progression of dopaminergic hypofunction in striatal subregions in Parkinson's Disease using [18F]CFT PET. Synapse 48:109–115. DOI: 10.1002/syn 0.10192
    Article PubMed CAS Google Scholar
  40. Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413–421
    Article PubMed CAS Google Scholar
  41. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C (2003) Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 23(8):3295–3301
    PubMed CAS Google Scholar
  42. Staffen W, Mair A, Unterrainer J, Trinka E, Ladurner G (2000) Measuring the progression of idiopathic Parkinson's disease with [123 I] β–CIT SPECT. J Neural Transm 107:543–552
    Article PubMed CAS Google Scholar
  43. Summerfield C, Junqué C, Tolosa E, Salgado–Pineda P, Gómez–Ansón B, Martí MJ, Pastor P, Ramírez–Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia. A voxel–based morphometry study. Arch Neurol 62:281–285
    Article PubMed Google Scholar
  44. Tachibana H, Kawabata K, Tomino Y, Sugita M, Fukuchi M (1993) Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three–dimensional surface display with 123I–iodoamphetamine. Dementia 4(6):334–341
    PubMed CAS Google Scholar
  45. Tisserand DJ, van Boxtel MP, Pruessner JC, Hofman P, Evans AC, Jolles J (2004) A Voxel–based morphometric study to determine differences in gray matter density associated with age and cognitive change over time. Cereb Cortex 14:966–973; DOI: 10.1093/cercor/bhh057
    Article PubMed Google Scholar
  46. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J (2002) Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72:491–497
    PubMed CAS Google Scholar
  47. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen, JC (1993) The locus ceruleus and dementia in Parkinson's disease. Neurology 43:986–991
    PubMed CAS Google Scholar

Download references